Berikutnya

Putar otomatis

MRD’s Potential Role in Treating Acute Myeloid Leukemia

0 Tampilan • 07/04/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Harry Erba, MD, PhD; Alexander E. Perl, MD; Eunice Wang, MD; and Jorge E. Cortes, MD, debate the current value of minimal residual disease testing for therapeutic decision-making in acute myeloid leukemia and identify the needs to be addressed before use in standard practice.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis